Improvement of gut-vascular barrier by terlipressin reduces bacterial translocation and remote organ injuries in gut-derived sepsis

Gut-vascular barrier (GVB) serves as the last barrier to limit the migration of intestinal toxins into the blood circulation. The efficacy of terlipressin (a vasopressin V1 receptor agonist) in reducing GVB and multiple organ damage in gut-derived sepsis is unknown. In this study, we hypothesized th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Zenan, Zhang, Yinan, Lin, Ming, Wen, Shihong, Lai, Hanjin, Zhan, Yaqing, Zhu, Xiufen, Huang, Zhikun, Zhang, Xuyu, Liu, Zimeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585222/
https://www.ncbi.nlm.nih.gov/pubmed/36278213
http://dx.doi.org/10.3389/fphar.2022.1019109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585222/
https://www.ncbi.nlm.nih.gov/pubmed/36278213
http://dx.doi.org/10.3389/fphar.2022.1019109

Ejemplares similares